Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2025-05-14 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is dated May 14, 2025, and reports the outcome of a Board Meeting held on the same day. It announces the approval of the Unaudited Financial Statements for the quarter ended March 31, 2025, which is a quarterly period shorter than a full fiscal year. The document includes detailed financial data such as revenue, expenses, profit before tax, tax expenses, and earnings per share for the quarter, as well as comparative figures for previous quarters and the prior year. It also contains a Limited Review Report by statutory auditors, which is typical for interim or quarterly financial statements. The presence of substantive financial data and analysis confirms this is a comprehensive quarterly financial report rather than a mere announcement or press release. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2025-05-14 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-09 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board of Directors meeting scheduled to consider and approve unaudited financial statements for the quarter ended 31st March 2025. It also mentions the closure of the trading window related to the publication of these financial statements. The document is short (1838 characters) and serves as an announcement of a future event rather than containing any financial data or results itself. It does not contain actual financial statements or detailed analysis, nor is it a transcript or report. Therefore, it fits the category of a Board/Management Information announcement regarding a board meeting and related compliance disclosures under SEBI regulations.
2025-05-09 English
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve the Unaudited Financial Statements ....
Regulatory Filings Classification · 95% confidence The document is a notification dated 9th May 2025 from Sanofi India Limited addressed to stock exchanges about an upcoming Board of Directors meeting scheduled for 14th May 2025. The purpose of the meeting is to consider and approve the unaudited financial statements for the quarter ended 31st March 2025. It also mentions the closure of the trading window related to the publication of these financial statements. The document does not contain any financial data or the actual financial report but is an announcement about the meeting and related procedural information. Therefore, it is not an Interim/Quarterly Report (IR) itself but a regulatory announcement about the meeting and financial results approval. This fits the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-05-09 English
Change in Management
Board/Management Information Classification · 95% confidence The document is a formal notification addressed to stock exchanges about a change in senior management personnel, specifically the resignation of Ms. Yasmin Shenoy, Head of Regulatory Affairs. It references compliance with SEBI Listing Regulations, which govern disclosures related to management changes. The content includes resignation details, effective dates, and a resignation letter. There are no financial statements, earnings data, or report attachments. The document is a regulatory announcement about management change, fitting the category of Board/Management Information (MANG). The document length is 4651 characters, sufficient for a detailed announcement but not a full report. Therefore, the classification is MANG with high confidence.
2025-05-06 English
Resignation of Senior Management Personnel of the Company
Board/Management Information Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding a change in senior management personnel, specifically the resignation of Ms. Yasmin Shenoy, Head of Regulatory Affairs. It references compliance with SEBI Listing Regulations, which govern disclosures of such changes. The content includes resignation details, effective dates, and an annexure with required regulatory information. There are no financial statements, earnings data, or report attachments. The document is a regulatory announcement about management change, fitting the category of Board/Management Information (MANG). The document length is 4641 characters, which is consistent with a detailed announcement rather than a full report or a brief notice. Therefore, the classification is MANG with high confidence.
2025-05-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.